Multiple myeloma is when the plasma cells grow out of control and become cancerous. It can sometimes be mistaken for other plasma cell disorders like: This staging classifies myeloma in three ...

A multiple myeloma diagnosis is a life event that can be overwhelming. Get trusted information for every step of your journey. Multiple myeloma can be tricky. That’s because it sometimes has no ...

It’s true that we’ve come a long way in recent years when it comes to treating multiple myeloma. More therapies are being developed, to the point where somebody diagnosed now is likely to have ...

Despite being the second most common haematologic cancer globally, treatment options for multiple myeloma remain limited, with a significant need for new therapies. 1 Multiple myeloma originates i ...

B-cell maturation antigen–directed chimeric antigen receptor (CAR) T-cell therapy demonstrated safety in patients with multiple myeloma (MM ... positive findings on brain/cranial nerve and ...

A four-drug regimen offers superior disease control and response depth in multiple myeloma compared to three-drug regimens. Adding monoclonal antibodies like Darzalex to standard treatments improves ...

Multiple myeloma is a relatively uncommon cancer of plasma cells, where excessive proliferation of these malignant cells within the bone marrow leads to abnormal antibody production. The disease ...

Darzalex and Revlimid maintenance resulted in superior outcomes versus Revlimid alone following autologous stem cell ...

The discoveries were made ... Epstein-Barr Virus and Brain Cross-Reactivity: Possible Mechanism for Multiple Sclerosis June 6, 2024 — The role that Epstein-Barr Virus (EBV) plays in the ...

The advent of chimeric antigen receptor (CAR) T-cell therapies has brought numerous advantages to the multiple ... the “brain-to-vein” time? What that means is 80% of patients [with myeloma ...